The suspicion that an immune reaction is involved at some stage in the pathogenesis of multiple sclerosis is implicit in much of the recent literature of the disease (Miller and Schapira, 1959) . If this were so, multiple sclerotic subjects might possibly manifest an enhanced capacity to produce antibodies; or alternatively, if they are actively producing auto-antibodies, then their capacity to respond to other antigens might be diminished.
To explore these possibilities the responses of multiple sclerotic patients to the inoculation of a standard typhoid-paratyphoid vaccine (T.A.B.T., Burroughs-Wellcome) have been evaluated and compared with those in normal subjects.
Method
In this series 21 multiple sclerotics and 23 control subjects were examined. The latter were physically healthy high-grade mental defectives, actively employed, and taken to represent 'normal controls'. The patients with multiple sclerosis were in various stages of the disease but no apparent differences were noted in the responses obtained.
In each case a Widal test was carried out before the first injection to serve as a 'base-line', after which 05 ml. T.A.B.T. No. 1 (Wellcome) was injected into the deltoid muscle of the non-dominant arm. This No. 1 antigen is a vaccine comprising heat-killed organisms as follows:-S. typhi 500 S. paratyphi A 250 Smillion organisms in I ml. S. paratyphi B 250 J The first few multiple sclerosis patients were confined to bed for 48 hours after inoculation and their temperatures recorded four-hourly, but in the absence of any constitutional reactions this procedure was soon abandoned.
At To meet the possibility that a short-lived response to injection might disappear within a month, and be missed when the next Widal test was done, a subsidiary experiment was carried out in which Widal tests were done one week (and sometimes again two weeks) after inoculation with T.A.B.T. No. 2. Eight multiple sclerosis patients and 15 controls were investigated in this way. The results of this series are set out in Table I .
No therapeutic effect was noted amongst the multiple sclerotic patients, though one or two reported temporary subjective improvement. On the other hand no untoward effects were observed in either the control or the experimental group.
The Widal test (or more strictly the 'tube agglutination test') as carried out routinely in this hospital was used throughout. The antigen employed was that supplied by the Standards Laboratory of the Public Health Laboratory Service. The range of serum dilutions was 1 : 25, 1: 50, 1: 125, 1: 250, 1: 500, 1: 1,000, 1: 2,500, 1: 5,000, 1: 10,000, 1: 20,000, 1: 50,000, and 1: 100,000. Incubation was carried out in a water-bath for four hours at 50°C., the tubes being stored overnight and read the next morning after having remained at room temperature for 30 minutes.
Results
In assessing the results of the short-term experiment presented in Table I If a two-tube rise from the zero base-line is accepted as certainly positive, then x2 (with Yates' correction) = 4-518 and P = 0-02. There is less than one chance in 500 that this difference is coincidental.
response which is being assessed. Under these conditions analysis shows a significantly greater response by control subjects than by multiple sclerosis cases. The changes in BO agglutinins were not significant, nor were those in any of the other titres which were examined.
The long-term experiments indicated that the difference between control and multiple sclerosis cases noted above was a transient phenomenon, and that in both groups repeated monthly inoculations produced a variable and uniformly ill-sustained response in all 0 titres.
To the question propounded in the introduction to this paper it seems possible to give a definite answer. Established cases of multiple sclerosis show a diminished immediate TO response as compared with normal subjects. On the other hand no differences are found during a subsequent period of six months or more. The incidental finding that normal subjects manifest only a moderate response, which may level off or prove poorly sustained, was unexpected after such intensive administration of vaccine.
(Considerations of space prevent the publication of detailed protocols. Records of antibody responses extending in some cases up to 10 months are available and would be gladly supplied to anyone wishing for detailed information.)
Discussion
The main object of this study was to investigate the immune response in multiple sclerosis, and from this point of view it would appear that sufferers from this disease react less vigorously to TO antigen than do control cases. The significance of this empirical finding will be evident only when information is available about the response encountered in patients with other nervous disorders causing comparable grades of 'debility': no difference related to the degree of disablement was noted in the present study.
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